Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.
暂无分享，去创建一个
M. Weisman | L. Moreland | J. Dayer | J. Frazier | C. Edwards | T. Kohno | A. Bendele | J. Seely | M. Sack | J. Caldwell | A. M. Cohen | M. E. Cosenza | D. McCabe | G. Henry | S. Lyons | S. W. Martin | C. L. Yee | D. Mccabe